MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS
Marpai (OTCQX: MRAI) has announced the comprehensive relaunch of MarpaiRx, a revolutionary pharmacy benefit management (PBM) solution targeting the $150 billion TPA market. The program, set to launch in H2 2025, aims to transform traditional PBM services with complete transparency and significant cost reductions.
MarpaiRx's key features include no hidden spreads or markups, real-time prescription optimization, integrated patient assistance programs, and international sourcing options. The platform tackles high specialty drug costs through a multi-pronged approach, including lowest net cost optimization and flexible copay programs. The solution leverages advanced technology for real-time analysis and seamless integration with existing health IT systems.
Marpai (OTCQX: MRAI) ha annunciato il rilancio completo di MarpaiRx, una soluzione rivoluzionaria di gestione dei benefici farmaceutici (PBM) rivolta al mercato TPA da 150 miliardi di dollari. Il programma, previsto per la seconda metà del 2025, mira a trasformare i servizi PBM tradizionali offrendo totale trasparenza e significative riduzioni dei costi.
Le caratteristiche principali di MarpaiRx includono assenza di margini nascosti o ricarichi, ottimizzazione delle prescrizioni in tempo reale, programmi integrati di assistenza ai pazienti e opzioni di approvvigionamento internazionale. La piattaforma affronta i costi elevati dei farmaci speciali con un approccio multiplo, comprendente l'ottimizzazione del costo netto più basso e programmi di copayment flessibili. La soluzione sfrutta tecnologie avanzate per analisi in tempo reale e integrazione fluida con i sistemi IT sanitari esistenti.
Marpai (OTCQX: MRAI) ha anunciado el relanzamiento integral de MarpaiRx, una solución revolucionaria de gestión de beneficios farmacéuticos (PBM) dirigida al mercado TPA de 150 mil millones de dólares. El programa, que se lanzará en la segunda mitad de 2025, tiene como objetivo transformar los servicios PBM tradicionales con total transparencia y reducciones significativas de costos.
Las características clave de MarpaiRx incluyen sin márgenes ocultos ni recargos, optimización de recetas en tiempo real, programas integrados de asistencia para pacientes y opciones de abastecimiento internacional. La plataforma aborda los altos costos de medicamentos especializados mediante un enfoque múltiple, que incluye la optimización del costo neto más bajo y programas flexibles de copago. La solución utiliza tecnología avanzada para análisis en tiempo real e integración fluida con los sistemas de TI de salud existentes.
Marpai (OTCQX: MRAI)는 1500억 달러 규모의 TPA 시장을 겨냥한 혁신적인 약국 혜택 관리(PBM) 솔루션인 MarpaiRx의 전면적인 재출시를 발표했습니다. 2025년 하반기 출시 예정인 이 프로그램은 완전한 투명성과 상당한 비용 절감을 통해 기존 PBM 서비스를 혁신하는 것을 목표로 합니다.
MarpaiRx의 주요 특징으로는 숨겨진 마진이나 추가 비용 없음, 실시간 처방 최적화, 통합 환자 지원 프로그램, 국제 조달 옵션 등이 있습니다. 이 플랫폼은 최저 순 비용 최적화 및 유연한 본인부담금 프로그램을 포함한 다각적 접근 방식을 통해 고가 전문 의약품 비용 문제를 해결합니다. 또한 첨단 기술을 활용해 실시간 분석과 기존 건강 IT 시스템과의 원활한 통합을 제공합니다.
Marpai (OTCQX : MRAI) a annoncé la relance complète de MarpaiRx, une solution révolutionnaire de gestion des prestations pharmaceutiques (PBM) ciblant le marché TPA de 150 milliards de dollars. Le programme, prévu pour le second semestre 2025, vise à transformer les services PBM traditionnels avec une transparence totale et des réductions de coûts significatives.
Les principales caractéristiques de MarpaiRx comprennent l'absence de marges ou majorations cachées, l'optimisation des prescriptions en temps réel, des programmes d'assistance aux patients intégrés et des options d'approvisionnement international. La plateforme s'attaque aux coûts élevés des médicaments spécialisés grâce à une approche multiple, incluant l'optimisation du coût net le plus bas et des programmes de copaiement flexibles. La solution utilise une technologie avancée pour une analyse en temps réel et une intégration fluide avec les systèmes informatiques de santé existants.
Marpai (OTCQX: MRAI) hat die umfassende Neugestaltung von MarpaiRx angekündigt, einer revolutionären Lösung für das Pharmacy Benefit Management (PBM), die den 150-Milliarden-Dollar-TPA-Markt adressiert. Das Programm, das in der zweiten Hälfte des Jahres 2025 starten soll, zielt darauf ab, traditionelle PBM-Dienste mit vollständiger Transparenz und erheblichen Kosteneinsparungen zu transformieren.
Zu den Hauptmerkmalen von MarpaiRx gehören keine versteckten Aufschläge oder Margen, Echtzeit-Optimierung von Verschreibungen, integrierte Patientenunterstützungsprogramme und internationale Beschaffungsoptionen. Die Plattform geht die hohen Kosten für Spezialmedikamente mit einem vielschichtigen Ansatz an, einschließlich der Optimierung der niedrigsten Nettokosten und flexiblen Zuzahlungsprogrammen. Die Lösung nutzt fortschrittliche Technologie für Echtzeitanalysen und nahtlose Integration in bestehende Gesundheits-IT-Systeme.
- Revolutionary transparent PBM model with no hidden fees or markups
- Advanced technology platform for real-time prescription cost optimization
- Multi-pronged approach to reduce specialty drug costs
- Flexible pharmacy network and international sourcing options for cost savings
- Integration capabilities with existing health IT systems
- Currently trading on OTCQX market rather than major exchange
- Implementation and market adoption pending until H2 2025
MarpaiRx Delivers a Win-Win for Health Plans and Members
As one of the cornerstones of the Marpai Saves vision, MarpaiRx breaks the mold of traditional PBMs by offering complete transparency. MarpaiRx contains no hidden spreads, no surprise markups, and offers real savings for health plans and members. The Company plans to actively offer the new program in the second half of 2025 to existing and new clients.
"According to a 2024 study by America's Health Insurance Plans (AHIP), over
MarpaiRx Delivers a Win-Win for Health Plans and Members:
- Unmatched Transparency: We believe in full disclosure. You see exactly what you're paying for medications, with no hidden fees.
- Lowest Net Cost Approach: Our cutting-edge technology finds the most cost-effective, clinically appropriate medications for each member, every time.
- Superior Member Experience: We streamline Rx delivery, prior authorizations, financial assistance coordination, and more to make the pharmacy experience seamless for your members.
- Flexible Pharmacy Network: Our system searches a vast network of pharmacies to ensure you get the absolute best price on every prescription.
Slashing Specialty Drug Costs:
MarpaiRx tackles the high cost of specialty medications with a multi-pronged approach:
- Lowest Net Cost Optimization: We go beyond rebates to find the most cost-effective options, prioritizing lower list price drugs with similar efficacy.
- Integrated Patient Assistance: Our system works to enroll eligible members in manufacturer copay assistance programs.
- International Sourcing: For specific medications, we leverage international sourcing to secure significant discounts while maintaining supply chain integrity.
- Flexible Copay Programs: We design customized plans that incentivize members to choose the most cost-effective specialty medications.
Real-Time Technology Drives Better Outcomes:
MarpaiRx is powered by a robust technology platform that delivers:
- Real-Time Optimization: Prescriptions are analyzed in real-time to identify the lowest net cost option and automatically apply relevant assistance programs.
- Seamless Provider and Patient Experience: Our provider and member portals and apps simplify prescribing and medication management.
- Actionable Insights: Sophisticated data analytics provide continuous monitoring of utilization, identify further savings opportunities, and empower you to make informed decisions.
- Flexibility and Integration: Open APIs allow for integration with existing health IT systems, fostering a holistic view of member health.
MarpaiRx – A Smarter Approach to Pharmacy Benefits
MarpaiRx empowers health plans to deliver exceptional value to their members. With unmatched transparency, significant cost savings, and superior member experience, we believe that MarpaiRx is the future of PBMs.
About Marpai, Inc.
Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the
Forward-Looking Statement Disclaimer
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses the benefits that may be realized through the use of MarpaiRx, the expected timing of the new program, and the belief that MarpaiRx is the future of PBMs Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.
More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.
View original content to download multimedia:https://www.prnewswire.com/news-releases/marpairx-revolutionizes-pharmacy-benefits-with-unprecedented-transparency-and-savings-302512541.html
SOURCE Marpai
FAQ
What is MarpaiRx's new PBM solution and when will it launch?
How does MarpaiRx plan to reduce specialty drug costs?
What technology features does the MarpaiRx platform offer?
How much of healthcare spending goes to prescription drugs according to MRAI's press release?
What market is Marpai (MRAI) targeting with its PBM solution?
